Neurosurgery notes/Tumours/Tumour general/Paediatric Cranial tumours

Paediatric Cranial tumours

View Details

For all tumour

  • Paediatric brain tumours, 2nd only to haematological malignancies
  • Overall incidence approximately 5/100,000 persons/year (compared to 20-30/100,000 in adults)
  • 60-70% are gliomas;
  • Age variation for all tumours
    • Commonest cancers in <1 year:
      Commonest cancers 1-10 years:
      Commonest cancers >10 years:
      Neuroblastoma
      Leukaemia
      Germ cell tumours
      CNS tumours
      Wilms tumour
      Leukaemia's
      CNS tumours
      Neuroblastoma
      Wilms tumor
      Germ cell tumors/Soft tissue sarcoma
      Leukemias
      CNS tumors
      Lymphoma
      Bone tumors/Soft tissue sarcomas
      Germ cell tumors
  • Childhood mortality UK
    • Brain tumours 35%
    • Leukaemia 21%
    • Tumours of other sites 44%

For CNS tumours

  • Most common malignant paediatric tumour: Medulloblastoma
  • Most common paediatric tumour is pilocytic astrocytoma
  • Specific frequency for all ages
    • Astrocytomas 30%, 0.84/100,000/year
    • Medulloblastoma (15-20%), 0.65/100,000/year
    • Craniopharyngioma (10-15%), 0.73/100,000/year
    • Ependymomas (5-10%), 0.28/100,000/year
    • germ cell tumours (5-10%)
  • Primary childhood CNS tumors incidence by WHO group:
    • Neuroepithelial tissue: 3.7/100,000
      • Astrocytic: 1.3/100,000/year
      • Ependymoma: 0.28/100,000/year
    • Sellar region: 0.73/100,000/year
    • Embryonal CNS tumors: 0.65/100,000/year
    • Neuronal and mixed neuronal-glial: 0.37/100,000/year
    • Unclassified: 0.3/100,000/year
    • Cranial and paraspinal nerves: 0.27/100,000/year
    • Meninges: 0.22/100,000/year
    • Germ cell tumors and cysts: 0.21/100,000/year
    • Lymphoma and hemopoetic: 0.03/100,000/year
  • Age variation for CNS tumours
    • 0-4 years
      5-9 years
      10-14 years
      15-19 years
      Gliomas (excluding PA)
      Pilocytic astrocytoma
      Medulloblastoma
      PNET
      Pituitary tumors
      Gliomas (excluding PA)
      Pilocytic astrocytoma
      Medulloblastoma
      PNET
      Pituitary tumors
      Gliomas (excluding PA)
      Pilocytic astrocytoma
      Medulloblastoma
      PNET
      Pituitary tumors
      Gliomas (excluding PA)
      Pilocytic astrocytoma
      Medulloblastoma
      PNET
      Pituitary tumors
      Age dependent relative fq
      notion image
      Congenital brain tumours < 60 days
      • Extremely rare, 0.5-1.5%
      • Improved fetal USG and fetal/neonatal MRI
      • Distinct histological and clinical behaviour compared to tumours of infancy (1-2 years old)
      • The most common type is teratoma (26.6% to 48%)
        • Frequently occur before 32 weeks of gestation
        • Resemble normal embryonic development
        • Possibly due to aberrant and residual cells during the formation of CNS
      • Others:
        • Astrocytoma (7.4% to 28.8%)
        • Choroid plexus papilloma (3.7% to 13.2%)
        • Embryonal tumor (3% to 13%)
      Tumors in Young Children (<3 years old)
      • Supratentorial tumors:
        • Ratio: 1.5:1 (more common than infratentorial)
      • Common types:
        • High-grade astrocytomas
        • Ependymomas
        • Medulloblastomas
      • Other rare embryonal tumors:
        • Supratentorial PNET (Primitive Neuroectodermal Tumor)
        • ATRT (Atypical Teratoid Rhabdoid Tumor)
      Location
      • Supratentorial tumours are more common in <3 years
      • Posterior fossa tumours are more common between 3-11 years
        • Paediatric PF tumours are less common than superior tentorial tumour
        • Posterior fossa tumours
          • Commoner in children over 1 year old
            • Constitute just under 2/3 of intracranial tumours >1
          • Supratentorial commoner in < 1
          • Only 15% in adults.
      Tumour
      % of posterior fossa tumours in children
      Pilocytic astrocytomas
      35%
      Medulloblastoma
      30%
      Ependymomas
      20-30%
      Brainstem gliomas
      10-20%
      Most common location:
  • Paediatric brain mets
      • Overall rate approximates 4% in patient followed up > 10 years.
      • Cerebral hematogenous metastases were reported in (Curless
        2002
        )
       
      4.4%
      Neuroblastoma
      1.9%
      Rhabdomyosarcoma
      6.5%
      Osteosarcoma
      3.3%
      Ewing sarcoma patients
      3.6%
      melanoma patients
      13.5%
      germ cell tumors
      1.3%
      Wilms tumor
       

Treatment decision making

  • Importance of avoidance of morbidity , in particular endocrine and hypothalamic functions which may affect growth
  • Long term sequelue with chemo/RT

Common syndromes

  • Nevoid basal cell carcinoma syndrome (Gorlin's syndrome)
  • Turcot's syndrome A
  • Li-Fraumeni syndrome
  • Rubinstein-Taybi syndrome